Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-04-25 | New | $250,000 | $250,000 | Equity Only | 06b | SEC link |
| 2025-02-11 | New | $250,000 | $250,000 | Equity Only | 06b | SEC link |
| 2024-08-16 | New | $600,000 | $600,000 | Equity Only | 06b | SEC link |
| 2024-03-12 | New | $500,000 | $500,000 | Equity Only | 06b | SEC link |
| 2023-05-04 | New | $2,000,000 | $2,000,000 | Equity Only | 06b | SEC link |
| 2021-04-07 | New | $5,550,000 | Unknown | Equity Only | SEC link |
| Name | Role |
|---|---|
| Samuel G. Backenroth | Director |
| Andreas G. Grill | Director, Executive |
| Leo Guthart | Director |
| Shankar Hariharan | Director |
| Peter Van Ness | Executive |
| Steve Winick | Director |
| Peter Young | Director |